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Background
One of the major factors in cancer progression or relapse
in patients is the development of chemoresistance. The
heterogeneity of cancer subtypes often means that the
oncogene addictions are different between subtypes,
possibly between patients. We have developed an efficient
computational pipeline to filter, analyze, and interpret the
vast number of called mutations that differentiate between
genomes to identify a targeted list of genetic determinants
of phenotype; in this case drug resistant vs. sensitive
cancer cells.
Materials and methods
Called mutations are filtered for quality, depth coverage,
and frequency of the mutation in the mapped reads. Only
exonic regions are considered for further analysis. To
quickly eliminate mutations in a resistant sample that are
also present within the paired sensitive sample, we created
an efficient algorithm that dramatically reduces the
required search space. This is accomplished through the
creation of a hash table mapping to a balanced binary tree
of the individual chromosome mutation positions and
base changes of the sensitive parental line, reducing the
search space required to less than 1% of a brute force
algorithm approach. Subsequent analysis of the remaining
mutations interprets potential impact through two meth-
odologies. The first method predicts if the specific muta-
tion will have a synonymous or deleterious effect on the
gene expression; the second method examines the muta-
tions in aggregate for an individual gene under the
hypothesis that highly mutated genes have a higher prob-
ability of disrupting functionality.
Results
We have applied our bioinformatics pipeline to triple
negative breast cancer (TNBC) cells to identify mutations
that confer resistance to AMPI-109. AMPI-109 is an
internally developed drug molecule that potently induces
apoptosis in TNBC cells of various molecular subtypes, yet
has little to no effect on non-TNBC and non-tumorigenic
cell lines. To identify potential mechanisms of resistance,
we compared the transcriptome of the sensitive TNBC
BT-20 parental cell line against five AMPI-109 resistant
clones. Validation of the targeted mutations identified
from our pipeline are ongoing.
Conclusions
This work establishes an efficient computational pipeline
to quickly identify a targeted list of mutations potentially
enabling chemoresistance in cancer patients. Early detec-
tion of mechanisms of resistance may enable more perso-
nalized therapeutic treatments with improved efficacy
and survival. Moreover, this pipeline may be applied to
any massively parallel sequencing application, such as the
identification of somatic mutations in diseased tissue.
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